Nigeria

in page functions
Total population (2013) 173,615,345
Birth cohort (2013) 7,173,020
Surviving Infants (surviving to 1 year per year, 2013) 6,634,718
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 78/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 124/1000
World Bank Index, IDA (2012) 3.44
Gross Nation Income (per capita US$, 2012) 1,430
Co-financing status (2013) Intermediate
No. of districts/territories (2012) 774

GAVI support for Nigeria

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Health system strengthening (HSS) $44,704,000 $44,704,000 $35,000,949 78%
Immunisation services support (ISS) $47,324,000 $47,324,000 $47,324,000 100%
Injection safety support (INS) $12,630,270 $12,630,270 $7,791,770 62%
Measles SIA - Operational costs (OPC) $19,290,000 $19,290,000 $19,290,000 100%
Measles SIA (NVS) $10,971,896 $10,971,896 $10,971,896 100%
Meningitis A - campaign (NVS) $35,440,806 $56,152,806 $35,572,693 100%
Meningitis A - operational costs (OPC) $26,461,148 $44,661,148 $26,461,148 100%
Penta (NVS) $72,559,492 $110,691,492 $59,940,886 83%
Pneumo (NVS) $12,905,000 $127,920,000
Vaccine Introduction Grant $10,013,974 $10,013,974 $4,411,474 44%
Yellow Fever - campaign (NVS) $41,211,319 $65,683,319 $11,117,819 27%
Yellow Fever (NVS) $39,012,946 $39,012,946 $40,348,159 103%
YF - Operational costs (OPC) $23,587,000 $38,195,000 $11,065,000 47%
Total $396,111,851 $627,250,851 $309,295,794

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
41%

*
DTP3 - Official country estimates (2012) 57%
M:F sex ratio at birth (2013) 1.06
Household survey: DTP3 coverage for male (2011) 37.80%
Household survey: DTP3 coverage for female (2011) 36.20%
Household survey: Last DTP3 survey (2011) 45%
% districts achieving > 80% DTP3 coverage (2012) 15%
% districts achieving < 50% DTP3 coverage (2012) 42%
MCV WHO/UNICEF estimates (2012) 42%
Polio WHO/UNICEF estimates (2012) 59%

Breakdown of support

Non-vaccine support Vaccine support
49% 51%
$151,344,341 $157,951,451

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

25 March 2014

GAVI-supported Pneumo and Rota studies published thumb

GAVI-supported Pneumo and Rota studies published

Reviews highlight effectiveness of pneumococcal vaccine dosing schedule and importance of rotavirus surveillance.

28 February 2014

Poliomyelitis vaccination and immunization, Ethiopia

GAVI Alliance complements global polio eradication effort

Countries eligible for GAVI Alliance support invited to apply for funding for inactivated polio vaccine until 2015.

26 November 2013

WHO_Alejandro_Costa_Burkina Faso_Yellow fever-s.jpg

GAVI Alliance to support Nigeria's first new national yellow fever vaccination campaign in 30 years

Mass preventive campaign will protect close to 60 million children and adults.

close icon

modal window here